Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Synthetic peptide to the C-terminal end of human AIB1 conjugated to KLH.|
|Storage buffer||PBS, pH 7.4|
|Storage Conditions||-80° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay-dependent|
|Western Blot (WB)||1-5 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-23150 detects AIB1 in human samples.
MA1-23150 has been successfully used in Western blot procedures. A suggested positive control for this product is MCF-7 nuclear extracts.
MA1-23150 immunogen corresponds to a synthetic peptide to the C-terminal end of human AIB1 conjugated to KLH.
AIB1-AC3 recognizes AIB1, a member of the SRC-1 family of nuclear receptor coactivators with an apparent molecular weight of 160kDa. The AIB1 gene has been mapped to region 20q12 and has been shown to be amplified in breast tumors and pancreatic cancer cell lines. AIB1 interacts in a ligand-dependent fashion with the estrogen receptor to enhance estrogen-dependent transcriptional gene activation.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
CBP-interacting protein, amplified in breast cancer 1 protein, class E basic helix-loop-helix protein 42, receptor-associated coactivator 3, steroid receptor coactivator protein 3, thyroid hormone receptor activator molecule 1, RP5-1049G16.3, AIB-1, AIB1, CAGH16, CTG26, KAT13B, MGC141848, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP
TNRC14, AIB-1, AIB1, SRC3, pCIP, CTG26, CAGH16, bHLHe42, KAT13B, TRAM-1, TNRC16, RAC3, SRC-3, ACTR